The relevance of neuroinflammation in the development of AD is further confirmed by the fact that inflammation-related proteins, including the astroglia-based YKL40 [also known as chitinase 3 like 1 (CHI3L1)] and the microglia-based triggering receptor expressed on myeloid cells 2 (TREM2), are currently considered to be potential AD biomarkers in CSF or blood (Molinuevo et al., 2018). The gene discussed is TREM2; the disease is Alzheimer disease.